Latest Corporate news updates; Pharma Feb 3rd 2022... Feb 03
Latest pharma news update... Aug 02
Tecentriq is now the first and only single-agent cancer immunotherapy with three dosing options... May 08
Ogluo (Glucagon) is indicated treatment of severe hypoglycemia... Feb 15
New option extends dosing from two to four weeks, reducing medical visits and improving patient convenience ... Jan 15
Inceptua will have exclusive rights to distribute and commercialize Apealea in Europe... Dec 28
Subcutaneous administration is preferred by patients, physicians and healthcare providers, and is associated with a reduction in healthcare costs ... Dec 23
Blueprint Medicines requested priority review for this application, which, if granted, could result in a six-month review process... Dec 18
... Dec 01
The European Commission has granted marketing authorization for Supemtek®, a quadrivalent (four-strain) recombinant influenza vaccine, for the prevention of influenza in adults aged 18 ... Nov 20
The approval was based on the results of Phase III and Phase II clinical studies conducted globally to evaluate Fycompa as an adjunctive therapy in ... Nov 16
European Commission decision marks the first time a dual immunotherapy with limited chemotherapy is approved for patients with non-small cell lung cancer in the ... Nov 09
European Commission approves Roche’s Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer.... Nov 02
... Oct 27
Novartis gets European Commission approval For Enerzair Breezhaler asthma treatment ... Jul 09
RINVOQ will be used for the treatment of adults with Active Psoriatic Arthritis... Jun 08
... May 08
-Advertisements-
.jpeg)
Tuesday, October 06, 2026
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
